These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11925716)

  • 1. [Biology and imaging of neuroendocrine tumors].
    Baudin E; Dromain C
    Rev Prat; 2002 Feb; 52(3):268-73. PubMed ID: 11925716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
    Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
    Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis, staging and follow-up of neuroendocrine tumors: role of somatostatin receptors scintigraphy].
    Lebtahi R
    Ann Pathol; 2011 Nov; 31(5 Suppl):S83-4. PubMed ID: 22054471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Scintigraphy detection of somatostatin receptor in tumor diagnosis].
    Parkkila S; Ahonen A; Leinonen L; Salmela P
    Duodecim; 1996; 112(7):589-97. PubMed ID: 10592623
    [No Abstract]   [Full Text] [Related]  

  • 6. Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
    Zimmer T; Ziegler K; Bäder M; Fett U; Hamm B; Riecken EO; Wiedenmann B
    Gut; 1994 Apr; 35(4):471-5. PubMed ID: 8174983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of a neuroendocrine differentiated cystic pancreatic lesion by gallium-68-DOTATOC-PET/CT with inconclusive MRI, CT and ultrasound diagnosis].
    Fröling V; Denecke T; Pöllinger A; Schreiter NF
    Rofo; 2010 Feb; 182(2):175-7. PubMed ID: 19998214
    [No Abstract]   [Full Text] [Related]  

  • 8. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
    Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
    Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignancy prediction in endocrine pancreas neoplasias].
    Fernández-del Castillo C
    Rev Invest Clin; 2005; 57(3):481-7. PubMed ID: 16187709
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumour markers in neuroendocrine tumours.
    Oberg K; Janson ET; Eriksson B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
    Banzo J; Abós MD; Prats E; García F; Razola P
    Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
    [No Abstract]   [Full Text] [Related]  

  • 12. Imaging of neuroendocrine gastro-entero-pancreatic tumours using radiolabelled somatostatin analogues.
    Chiti A; van Graafeiland BJ; Savelli G; Ferrari L; Seregni E; Castellani MR; Bombardieri E
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S190-4. PubMed ID: 10604128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chromogranin A measurement in the work-up of neuroendocrine tumors.
    Baudin E; Bidart JM; Bachelot A; Ducreux M; Elias D; Ruffié P; Schlumberger M
    Ann Oncol; 2001; 12 Suppl 2():S79-82. PubMed ID: 11762357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Imaging strategy for staging and follow-up of endocrine tumors].
    Dromain C; Baudin E
    Bull Cancer; 2006 Dec; 93(12):1183-9. PubMed ID: 17182374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Somatostatin receptor scintigraphy (SRS) in a neuroendocrine pancreatic tumor: why SPECT?].
    Lang O; Bihl H
    Nuklearmedizin; 2000; 39(4):N55-7. PubMed ID: 10919167
    [No Abstract]   [Full Text] [Related]  

  • 16. [Parascapular lipoma with expression of somatostatin receptors detected by (99m)Tc-EDDA/HYNIC-TOC scintigraphy].
    Mendoza Narváez JA; Bellón Guardia ME; García Vicente AM; Palomar Muñoz A; Talavera Rubio MP; Soriano Castrejón AM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):225-6. PubMed ID: 23067692
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
    Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
    Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of chromogranins and chromogranin-related peptides by immunological methods.
    Stridsberg M
    Adv Exp Med Biol; 2000; 482():319-27. PubMed ID: 11192592
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of endocrine carcinoma of the rectum.
    Oshiro T; Yamamoto S
    Jpn J Clin Oncol; 2011 May; 41(5):730. PubMed ID: 21536694
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.